Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 6 of 6

Publication Record

Connections

An Informed and Activated Patient: Addressing Barriers in the Pathway From Education to Outcomes.
Wright Nunes JA, Cavanaugh KL, Fagerlin A
(2016) Am J Kidney Dis 67: 1-4
MeSH Terms: Anticholesteremic Agents, Educational Status, Ezetimibe, Female, Humans, Male, Renal Insufficiency, Chronic, Simvastatin
Added January 4, 2016
0 Communities
1 Members
0 Resources
8 MeSH Terms
Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.
Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM
(2010) Diabetes Obes Metab 12: 983-93
MeSH Terms: Anticholesteremic Agents, Azetidines, Cholesterol, LDL, Delayed-Action Preparations, Diabetes Mellitus, Type 2, Drug Combinations, Ezetimibe, Simvastatin Drug Combination, Female, Humans, Hyperlipidemias, Male, Metabolic Syndrome, Middle Aged, Niacin, Simvastatin, Treatment Outcome
Added December 10, 2013
0 Communities
1 Members
0 Resources
16 MeSH Terms
Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
Fazio S, Guyton JR, Polis AB, Adewale AJ, Tomassini JE, Ryan NW, Tershakovec AM
(2010) Am J Cardiol 105: 487-94
MeSH Terms: Adolescent, Adult, Aged, Azetidines, Biomarkers, C-Reactive Protein, Cholesterol, HDL, Cholesterol, LDL, Delayed-Action Preparations, Double-Blind Method, Drug Therapy, Combination, Ezetimibe, Female, Follow-Up Studies, Humans, Hyperlipidemias, Hypolipidemic Agents, Lipoproteins, Male, Middle Aged, Niacin, Severity of Illness Index, Simvastatin, Tennessee, Time Factors, Treatment Outcome, Vitamin B Complex
Added December 10, 2013
0 Communities
1 Members
0 Resources
27 MeSH Terms
Is Zetia a 'do nothing' drug?
Lindsley CW
(2008) Curr Top Med Chem 8: 434
MeSH Terms: Azetidines, Clinical Trials as Topic, Ezetimibe, Humans, Hypercholesterolemia, Hypolipidemic Agents, Molecular Structure
Added March 5, 2014
1 Communities
1 Members
0 Resources
7 MeSH Terms
Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.
Chuang P, Langone AJ
(2007) Am J Ther 14: 438-41
MeSH Terms: Adult, Aged, Anticholesteremic Agents, Azetidines, Cholesterol, LDL, Ezetimibe, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipidemias, Kidney Transplantation, Male, Middle Aged, Practice Guidelines as Topic, Retrospective Studies, Treatment Outcome
Added March 19, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors.
Langone AJ, Chuang P
(2006) Transplantation 81: 804-7
MeSH Terms: Adult, Aged, Anticholesteremic Agents, Azetidines, Cholesterol, LDL, Drug Resistance, Drug Therapy, Combination, Ezetimibe, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Kidney Transplantation, Male, Middle Aged, Retrospective Studies, Treatment Outcome, Triglycerides
Added March 19, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms